Beijing SL Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 776.63 million compared to CNY 826.97 million a year ago. Revenue was CNY 776.63 million compared to CNY 826.97 million a year ago.

Net income was CNY 317.57 million compared to CNY 237.95 million a year ago. Basic earnings per share from continuing operations was CNY 0.3091 compared to CNY 0.2316 a year ago. Diluted earnings per share from continuing operations was CNY 0.3091 compared to CNY 0.2316 a year ago.